Vinorelbine
Showing 51 - 75 of 598
Breast Cancer Metastatic Trial in Worldwide (MCLA-128, Trastuzumab, Vinorelbine)
Active, not recruiting
- Breast Cancer Metastatic
- MCLA-128
- +3 more
-
Los Angeles, California
- +24 more
Aug 10, 2022
Metastatic Breast Cancer Trial in Dallas (Anakinra plus Standard of Care)
Completed
- Metastatic Breast Cancer
- Anakinra plus Standard of Care
-
Dallas, TexasBaylor University Medical Center
Oct 7, 2021
NSCLC, Non-Small-Cell Lung Carcinoma, Circulating Tumor DNA Trial (biological, drug, other)
Withdrawn
- Non-Small Cell Lung Cancer
- +2 more
- Nivolumab
- +8 more
- (no location specified)
Mar 9, 2022
Breast Cancer Trial (capecitabine and trastuzumab, vinorelbine and trastuzumab)
Not yet recruiting
- Breast Cancer
- capecitabine and trastuzumab
- vinorelbine and trastuzumab
- (no location specified)
Jun 7, 2021
Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +
Not yet recruiting
- Breast Cancer
- +3 more
- AI+CDK4/6i
- +7 more
-
Miami, FloridaUniversity of Miami
Apr 12, 2023
Multiple Myeloma Trial in Berne (Vinorelbine, Gemcitabine, G-CSF)
Recruiting
- Multiple Myeloma
- Vinorelbine
- +2 more
-
Berne, SwitzerlandDepartment for Medical Oncology University Hospital/Inselspital
Jul 29, 2021
Cervical Cancer Trial in Algeria (Nimotuzumab ( h-R3), Placebo)
Completed
- Cervical Cancer
- Nimotuzumab ( h-R3)
- Placebo
-
Algiers, Algeria
- +4 more
Aug 22, 2021
Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation, Triple-Negative Breast Cancer Trial in Seattle (Veliparib,
No longer available
- Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation
- Triple-Negative Breast Cancer
- Veliparib
- +2 more
-
Seattle, WashingtonSeattle Cancer Care Allliance
Jul 14, 2021
Breast Cancer Trial in Beijing (RC48-ADC, Paclitaxel Injection, Docetaxel Injection)
Recruiting
- Breast Cancer
- RC48-ADC
- +4 more
-
Beijing, Beijing, ChinaOncology Hospital, Chinese Academy of Medical Sciences
Nov 24, 2021
NSCLC Trial in Denmark (Navelbine, 66 Gy/33F, 60 Gy/30F)
Metastatic Breast Cancer Trial in Frankfurt am Main (Palbociclib / Chemotherapy (capecitabine, epirubicin, paclitaxel,
Recruiting
- Metastatic Breast Cancer
- Palbociclib / Chemotherapy (capecitabine, epirubicin, paclitaxel, vinorelbine) / Endocrine therapy (exemestane, fulvestrant, letrozole, tamoxifen)
-
Frankfurt am Main, GermanyAgaplesion Markus Krankenhaus - Klinik für Gynäkologie und Gebur
Feb 22, 2022
Non Small Cell Lung Cancer Trial (Toripalimab, Toripalimab mimetic ())
Not yet recruiting
- Non Small Cell Lung Cancer
- Toripalimab
- Toripalimab mimetic (placebo)
- (no location specified)
Feb 23, 2021
Low-Grade Glioma Trial in France (ORAL VINORELBINE)
Completed
- Low-Grade Glioma
- ORAL VINORELBINE
-
Angers, France
- +15 more
Nov 17, 2020
Breast Cancer Trial in Washington (docetaxel, vinorelbine ditartrate)
Completed
- Breast Cancer
- docetaxel
- vinorelbine ditartrate
-
Washington, District of Columbia
- +1 more
Aug 12, 2020
Locally Advanced NSCLC Trial in Edinburgh, London, Oxford (Atovaquone Oral Suspension, Standard of care chemo, Standard of care
Recruiting
- Locally Advanced Non-Small Cell Lung Cancer
- Atovaquone Oral Suspension
- +2 more
-
Edinburgh, United Kingdom
- +1 more
Dec 21, 2021
NSCLC Stage III Trial in Paris, Milan, Barcelona (durvalumab plus platinum-based chemo (cisplatin or carboplatin plus
Recruiting
- Non-small Cell Lung Cancer Stage III
- durvalumab plus platinum-based chemotherapy (cisplatin or carboplatin plus vinorelbine or pemetrexed)
- +2 more
-
Paris, France
- +2 more
May 30, 2022
Pleural Mesothelioma Malignant Advanced Trial in Spain, Switzerland, United Kingdom (Pembrolizumab, Gemcitabine, Vinorelbine)
Completed
- Pleural Mesothelioma Malignant Advanced
- Pembrolizumab
- +2 more
-
Barcelona, Spain
- +14 more
Aug 23, 2022
Lymphoma Trial in Los Angeles (rituximab, vinorelbine ditartrate)
Completed
- Lymphoma
- rituximab
- vinorelbine ditartrate
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center, UCLA
Jul 30, 2020
Lung Cancer Trial in United States (gemcitabine HCl, paclitaxel poliglumex, vinorelbine tartrate)
Terminated
- Lung Cancer
- gemcitabine hydrochloride
- +2 more
-
Birmingham, Alabama
- +9 more
Oct 2, 2020
Hormone Receptor Positive Advanced Breast Cancer Trial in Beijing (fluvestrant + oral vinorelbine)
Unknown status
- Hormone Receptor Positive Advanced Breast Cancer
- fluvestrant + oral vinorelbine
-
Beijing, Beijing, ChinaNational Cacner Center/ Cancer Hospital,Chinese Academy of Medic
Jun 21, 2020
Breast Cancer Trial in Cleveland (celecoxib, vinorelbine ditartrate)
Terminated
- Breast Cancer
- celecoxib
- vinorelbine ditartrate
-
Cleveland, OhioIreland Cancer Center at University Hospitals Case Medical Cente
Jul 23, 2020